Cargando…
Effects of bamlanivimab alone or in combination with etesevimab on subsequent hospitalization and mortality in outpatients with COVID-19: a systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused an enormous loss of life worldwide. The spike protein of the severe acute respiratory syndrome coronavirus 2 is the cause of its virulence. Bamlanivimab, a recombinant monoclonal antibody, has been used alone or in combination with etesevima...
Autores principales: | Tai, Yu-Lin, Lee, Ming-Dar, Chi, Hsin, Chiu, Nan-Chang, Lei, Wei-Te, Weng, Shun-Long, Liu, Lawrence Yu-Min, Chen, Chung-Chu, Huang, Shih-Yu, Huang, Ya-Ning, Lin, Chien-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174063/ https://www.ncbi.nlm.nih.gov/pubmed/37180576 http://dx.doi.org/10.7717/peerj.15344 |
Ejemplares similares
-
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
por: Bavaro, DF, et al.
Publicado: (2022) -
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
por: Dougan, Michael, et al.
Publicado: (2021) -
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
por: Zhang, Lin, et al.
Publicado: (2021) -
Association between statin use and risk of gallstone disease and cholecystectomy: a meta-analysis of 590,086 patients
por: Chang, Yu, et al.
Publicado: (2023) -
Pentoxifylline decreases post-operative intra-abdominal adhesion formation in an animal model
por: Yang, Ya-Lin, et al.
Publicado: (2018)